First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
★ Analysts see FY2027 revenue reaching $15.3B — +6.3% growth in a single year.
What Moves the Stock
1Gucci brand health metrics - comparable store sales growth, new customer acquisition, product sell-through rates at full price
2Greater China luxury demand - Chinese consumer spending accounts for 30-35% of global luxury purchases, with mainland China representing 15-18% of Kering revenue
3Brand creative direction changes - designer appointments at Gucci, Saint Laurent, Bottega Veneta drive multi-year revenue cycles
4Wholesale channel destocking - department store inventory levels and reorder patterns signal underlying demand
5Euro/USD exchange rate - approximately 40% of revenue in Americas creates translation exposure
6Competitive market share dynamics versus LVMH (Louis Vuitton, Dior) and Hermès in leather goods category
7Gucci brand (estimated 48-52% of group revenue) - leather goods, ready-to-wear, shoes, accessories
8Yves Saint Laurent (estimated 18-20%) - high-growth brand with strong leather goods momentum
value/turnaround - Current depressed valuation (2.3x P/S versus LVMH 4.5x, Hermès 10x) attracts contrarian investors betting on Gucci…
Moderate sensitivity through multiple channels: (1) Higher rates reduce luxury goods affordability for aspirational consumers using credit…
Watch on earnings: China retail sales of consumer goods (monthly) - leading indicator for luxury demand recovery in largest growth market, Euro Stoxx Luxury Index relative performance - sector rotation signals and peer multiple expansion/compression, Gucci creative team stability - designer retention and collection reception drive 3-5 year brand cycles.
One Sentence Summary:
Kering: the story is balanced — gucci brand health metrics - comparable store sales growth, new customer acquisition, product sell-through rates at full price.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.